Analystreport

Blueprint Medicines Corp (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a price target on the stock, down previously from .

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com